Literature DB >> 21076074

Moral transhumanism.

Ingmar Persson1, Julian Savulescu.   

Abstract

In its basic sense, the term "human" is a term of biological classification: an individual is human just in case it is a member of the species Homo sapiens. Its opposite is "nonhuman": nonhuman animals being animals that belong to other species than H. sapiens. In another sense of human, its opposite is "inhuman," that is cruel and heartless (cf. "humane" and "inhumane"); being human in this sense is having morally good qualities. This paper argues that biomedical research and therapy should make humans in the biological sense more human in the moral sense, even if they cease to be human in the biological sense. This serves valuable biomedical ends like the promotion of health and well-being, for if humans do not become more moral, civilization is threatened. It is unimportant that humans remain biologically human, since they do not have moral value in virtue of belonging to H. sapiens.

Entities:  

Mesh:

Year:  2010        PMID: 21076074     DOI: 10.1093/jmp/jhq052

Source DB:  PubMed          Journal:  J Med Philos        ISSN: 0360-5310


  6 in total

1.  Risk, Russian-roulette and lotteries: Persson and Savulescu on moral enhancement.

Authors:  Darryl Gunson; Hugh McLachlan
Journal:  Med Health Care Philos       Date:  2013-11

2.  The gene-editing of super-ego.

Authors:  Bjørn Hofmann
Journal:  Med Health Care Philos       Date:  2018-09

3.  Enhancement and Civic Virtue.

Authors:  Will Jefferson; Thomas Douglas; Guy Kahane; Julian Savulescu
Journal:  Soc Theory Pract       Date:  2014-07

4.  Enhancing Moral Conformity and Enhancing Moral Worth.

Authors:  Thomas Douglas
Journal:  Neuroethics       Date:  2013-04-12       Impact factor: 1.480

5.  Moral Enhancement, Freedom and the God Machine.

Authors:  Julian Savulescu; Ingmar Persson
Journal:  Monist       Date:  2012-07

Review 6.  The ethical desirability of moral bioenhancement: a review of reasons.

Authors:  Jona Specker; Farah Focquaert; Kasper Raus; Sigrid Sterckx; Maartje Schermer
Journal:  BMC Med Ethics       Date:  2014-09-16       Impact factor: 2.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.